Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

2.1K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan.

Journal of translational medicine·2026
Same author

Aspiration to architecture: multi-omics, AI, digital twins, and blockchain for P4 medicine.

Journal of translational medicine·2026
Same author

Mesenchymal stem cells for recurrent miscarriage.

Journal of translational medicine·2026
Same author

Sex-based differences in clinical outcomes after physiology-guided deferral of coronary revascularization.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice.

Bone marrow transplantation·2026
Same author

Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 15, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

623

Reversing coma by senolytics and stem cells: the future is now.

Thomas E Ichim1, Roman A Ramos2, Armin Rath2

  • 1Immorta Bio Inc, Miami Beach, FL, USA. tichim@immortabio.com.

Journal of Translational Medicine
|October 7, 2025
PubMed
Summary

New therapies may reverse disorders of consciousness (DoC) caused by global cerebral ischemia (GCI). A two-step approach using senolytics and regenerative medicine offers hope for coma recovery.

More Related Videos

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

15.1K
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
09:15

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Published on: November 5, 2011

14.4K

Related Experiment Videos

Last Updated: Jan 15, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

623
Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

15.1K
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
09:15

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Published on: November 5, 2011

14.4K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cellular Biology

Background:

  • Global cerebral ischemia (GCI) is a primary cause of coma and disorders of consciousness (DoC).
  • Patient recovery potential is often underestimated due to outdated views on neurogenesis.
  • Emerging evidence suggests residual mental activity and communication in comatose patients.

Purpose of the Study:

  • To propose a novel therapeutic strategy for reversing disorders of consciousness.
  • To leverage recent advances in neurophysiology, regenerative medicine, and senescence biology.
  • To offer a realistic chance of recovery for patients with GCI-induced coma.

Main Methods:

  • A two-step therapeutic paradigm is proposed.
  • Step 1: Utilize senolytic approaches to clear senescent cells and reduce neuroinflammation.
  • Step 2: Stimulate neural regeneration via stem cell therapies, electrophysiologic, and pharmacological stimulation.

Main Results:

  • This integrated approach aims to address the challenge of coma reversal.
  • The strategy targets both neuroinflammation and neural regeneration.
  • Experimental interventions are proposed based on current scientific understanding.

Conclusions:

  • A novel treatment paradigm integrating senolytics and regenerative medicine is presented.
  • This approach offers a potential pathway to reverse disorders of consciousness.
  • The strategy addresses the limitations of historical treatment perspectives for coma patients.